128 studies found for:    glioblastoma | Open Studies | Exclude Unknown | Phase 2
Show Display Options
Rank Status Study
1 Not yet recruiting Phase II Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Drug: Temozolomide;   Biological: T Cell Infusion;   Procedure: Surgery;   Behavioral: Phone Calls
2 Not yet recruiting Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Conditions: Glioma;   Glioblastoma;   Glioblastoma Multiforme;   GBM;   Brain Cancer
Interventions: Drug: VAL-083;   Drug: Lomustine
3 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment
4 Recruiting Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
Condition: Glioblastoma
Intervention: Radiation: SRT to the resection cavity
5 Recruiting Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid
Condition: Glioblastoma
Intervention: Other: Platelet level determination
6 Not yet recruiting Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
Conditions: Glioblastoma;   Glioblastoma Multiforme;   Gliosarcoma;   Brain Neoplasms;   Central Nervous System Neoplasms
Interventions: Drug: topotecan;   Drug: pazopanib
7 Recruiting Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Conditions: Adult Brain Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose);   Drug: Bevacizumab
8 Recruiting Surgery for Recurrent Glioblastoma
Condition: Glioblastoma
Interventions: Procedure: Surgery followed by adjuvant second-line therapy;   Procedure: Second-line therapy alone
9 Recruiting A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma
Condition: Glioblastoma
Intervention: Drug: Bevacizumab 25 mg in 1 ml subcutaneously daily
10 Recruiting ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: ABT-414;   Drug: Lomustine;   Drug: Temozolomide
11 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
12 Recruiting Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Drug: TPI 287;   Drug: Bevacizumab
13 Recruiting FMISO PET Study of Glioblastoma
Condition: Recurrent Glioblastoma
Interventions: Device: FMISO PET;   Device: MRI;   Drug: Bevacizumab;   Drug: CCNU
14 Recruiting Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioblastoma
Conditions: Glioblastoma;   Astrocytoma
Intervention: Radiation: Rhenium Liposome Treatment
15 Recruiting Neoadjuvant Nivolumab in Glioblastoma
Condition: Glioblastoma Multiforme
Intervention: Drug: Nivolumab
16 Not yet recruiting Optune Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
Conditions: Glioblastoma;   Glioma;   Gliosarcoma
Interventions: Drug: Bevacizumab;   Device: TTFields
17 Recruiting Trial of Hypofractionated Radiation Therapy for Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Hypofractionated radiation therapy;   Radiation: Standard radiation therapy
18 Recruiting Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
Condition: Glioblastoma
Intervention: Biological: Personalized cellular vaccine
19 Recruiting Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma - Category
Interventions: Drug: Bevacizumab;   Procedure: Magnetic Resonance Spectroscopy (MRS);   Procedure: Border Zone Stereotactic Radiosurgery (BZ-SRS)
20 Recruiting Study of DC Vaccination Against Glioblastoma
Conditions: Glioma;   Glioblastoma Multiforme;   Neoplasms
Interventions: Procedure: Surgery;   Drug: Chemotherapy;   Radiation: Radiotherapy;   Biological: DC vaccination;   Drug: blank placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years